Cargando…

Repurposing Tecfidera for cancer

Detalles Bibliográficos
Autores principales:	Booth, Laurence, Malkin, Mark, Dent, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993329/ https://www.ncbi.nlm.nih.gov/pubmed/27429364 http://dx.doi.org/10.18632/aging.101001

Ejemplares similares

Wdr1 and cofilin are necessary mediators of immune-cell-specific apoptosis triggered by Tecfidera
por: Poganik, Jesse R., et al.
Publicado: (2021)

Rationally Repurposing Ruxolitinib (Jakafi(®)) as a Solid Tumor Therapeutic
por: Tavallai, Mehrad, et al.
Publicado: (2016)

A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatment
por: Baeva, Maria-Elizabeth, et al.
Publicado: (2021)

Economic impact of new active substance status on EU payers’ budgets: example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosis
por: Toumi, Mondher, et al.
Publicado: (2014)

Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera(®) (Dimethyl Fumarate)
por: Lategan, Thomas W., et al.
Publicado: (2021)

Repurposing ARBs as treatments for breast cancer
por: George, Amee J., et al.
Publicado: (2017)

Repurposing Tuft Cells to Suppress Pancreatic Cancer
por: Means, Anna L.
Publicado: (2020)

Repurposing of FDA-approved drugs against cancer – focus on metastasis
por: Ozsvári, Béla, et al.
Publicado: (2016)

Drug Repurposing and DNA Damage in Cancer Treatment: Facts and Misconceptions
por: Sertedaki, Eleni, et al.
Publicado: (2020)

Drug repurposing strategies for COVID-19
por: Senanayake, Suranga L
Publicado: (2020)

Repurposing Canagliflozin to target brain aging
por: Jayarathne, Hashan, et al.
Publicado: (2023)

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
por: Yu, Yingyan
Publicado: (2021)

Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study): Study protocol clinical trial (SPIRIT Compliant)
por: Vucic, Steve, et al.
Publicado: (2020)

Biocomputing drug repurposing toward targeted therapies
por: Cardone, Luca
Publicado: (2016)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

Trends and Applications in Computationally Driven Drug Repurposing
por: Pinzi, Luca, et al.
Publicado: (2023)

New opportunities for kinase drug repurposing and target discovery
por: Knapp, Stefan
Publicado: (2018)

Immunosuppression for COVID-19: repurposing medicines in a pandemic
por: Shivakumar, Senthuran, et al.
Publicado: (2020)

Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
por: Fender, Anke C., et al.
Publicado: (2020)

Repurposing Cardio-Metabolic Drugs to Fight Covid19
por: Battistoni, Allegra, et al.
Publicado: (2021)

Repurposing Propofol as a Prognostic Probe for Return of Consciousness
por: Avidan, Michael S., et al.
Publicado: (2021)

Drug repurposing: a nexus of innovation, science, and potential
por: De Rosa, Maria Cristina, et al.
Publicado: (2023)

GZ17-6.02 kills prostate cancer cells in vitro and in vivo
por: Booth, Laurence, et al.
Publicado: (2022)

Ibrutinib repurposing: from B-cell malignancies to solid tumors
por: Massó-Vallés, Daniel, et al.
Publicado: (2016)

Repurposing paclitaxel for the treatment of fibrosis: indication discovery for existing drugs
por: Chen, Xiao-Wu, et al.
Publicado: (2015)

Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia
por: Leucht, Stefan, et al.
Publicado: (2022)

Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2022)

Metabolism of Histone Deacetylase Proteins Opsonizes Tumor Cells to Checkpoint Inhibitory Immunotherapies
por: Dent, Paul, et al.
Publicado: (2019)

Repurposing A549 Adenocarcinoma Cells: New Options for Drug Discovery
por: Garcia-de-Alba, Carolina
Publicado: (2021)

Repurposing an ‘Old’ Drug for the Treatment of COVID-19-Related Cytokine Storm
por: Pontali, Emanuele, et al.
Publicado: (2023)

Reverse Cholesterol Transport of Macrophages Repurposed for Hepatitis B Virus Entry
por: Cheng, Yun, et al.
Publicado: (2023)

Stereotactic body radiation therapy for metastatic non-small cell lung cancer: a versatile treatment, repurposed
por: Shen, James L., et al.
Publicado: (2022)

Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
por: Diao, James A., et al.
Publicado: (2022)

Impact of Nutrition or FDA-Approved Medicine Repurposing on Metabolic Syndrome and Diabetic Complications
por: Cai, Lu
Publicado: (2023)

Does the oncology community have a rejection bias when it comes to repurposed drugs?
por: Gyawali, Bishal, et al.
Publicado: (2018)

Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders
por: Villoutreix, Bruno O., et al.
Publicado: (2020)

Repurposing the systemic venous return model for conceptualisation of chronic venous insufficiency and its management
por: Normahani, Pasha, et al.
Publicado: (2020)

Cladribine repurposed in multiple sclerosis: making a fortune out of a generic drug
por: Buiter, Hans J C, et al.
Publicado: (2019)

Potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma
por: Horie, Kuniko, et al.
Publicado: (2023)

GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells
por: Booth, Laurence, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2vdeuu4upb10ur2mo7hr2pqdn7